Next Article in Journal
A Concise Route for the Synthesis of Tetracyclic Meroterpenoids: (±)-Aureol Preparation and Mechanistic Interpretation
Previous Article in Journal
In-Depth In Silico Search for Cuttlefish (Sepia officinalis) Antimicrobial Peptides Following Bacterial Challenge of Haemocytes
Open AccessReview

Current Research Landscape of Marine-Derived Anti-Atherosclerotic Substances

1
Marine College, Shandong University, Weihai 264209, China
2
School of Pharmaceutical Sciences, Shandong University, Jinan 250012, China
*
Authors to whom correspondence should be addressed.
Mar. Drugs 2020, 18(9), 440; https://doi.org/10.3390/md18090440
Received: 23 July 2020 / Revised: 19 August 2020 / Accepted: 20 August 2020 / Published: 25 August 2020
Atherosclerosis is a chronic disease characterized by lipid accumulation and chronic inflammation of the arterial wall, which is the pathological basis for coronary heart disease, cerebrovascular disease and thromboembolic disease. Currently, there is a lack of low-cost therapeutic agents that effectively slow the progression of atherosclerosis. Therefore, the development of new drugs is urgently needed. The research and development of marine-derived drugs have gained increasing interest from researchers across the world. Many marine organisms provide a rich material basis for the development of atherosclerotic drugs. This review focuses on the latest technological advances in the structures and mechanisms of action of marine-derived anti-atherosclerotic substances and the challenges of the application of these substances including marine polysaccharides, proteins and peptides, polyunsaturated fatty acids and small molecule compounds. Here, we describe the theoretical basis of marine biological resources in the treatment of atherosclerosis. View Full-Text
Keywords: atherosclerosis; marine active substances; polysaccharides; proteins and peptides; polyunsaturated fatty acids; small molecule compounds atherosclerosis; marine active substances; polysaccharides; proteins and peptides; polyunsaturated fatty acids; small molecule compounds
Show Figures

Figure 1

MDPI and ACS Style

Cao, Q.; Zhao, J.; Xing, M.; Xiao, H.; Zhang, Q.; Liang, H.; Ji, A.; Song, S. Current Research Landscape of Marine-Derived Anti-Atherosclerotic Substances. Mar. Drugs 2020, 18, 440. https://doi.org/10.3390/md18090440

AMA Style

Cao Q, Zhao J, Xing M, Xiao H, Zhang Q, Liang H, Ji A, Song S. Current Research Landscape of Marine-Derived Anti-Atherosclerotic Substances. Marine Drugs. 2020; 18(9):440. https://doi.org/10.3390/md18090440

Chicago/Turabian Style

Cao, Qi; Zhao, Jiarui; Xing, Maochen; Xiao, Han; Zhang, Qian; Liang, Hao; Ji, Aiguo; Song, Shuliang. 2020. "Current Research Landscape of Marine-Derived Anti-Atherosclerotic Substances" Mar. Drugs 18, no. 9: 440. https://doi.org/10.3390/md18090440

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop